ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,134.00
0.59%
다우존스 지수
38,686.32
1.51%
Bitcoin
69,135.48
2.06%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Organogenesis Holdings Inc (ORGO)

  7. Organogenesis Holdings Inc (ORGO) 뉴스

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ORGO
일자시간출처헤드라인심볼기업
2024/05/1005:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
2024/05/1005:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
2024/05/0220:00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
2024/04/1620:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
2024/04/0320:30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
2024/03/0106:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
2024/03/0106:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
2024/03/0106:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2407:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2110:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2110:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2110:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2110:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/2110:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/1221:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/0906:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
2024/02/0223:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ORGOOrganogenesis Holdings Inc
2024/01/1006:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
2023/11/1006:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
2023/11/1006:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
2023/11/1006:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
2023/11/1006:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
 검색 관련기사 보기:NASDAQ:ORGO

최근 히스토리

COIN
ORNUST
Orion Protocol
USOTC
ERAO
Energy Revenue America (PK)
TG
5UK
Alaris Equity Partners I...
ASX
EPN
Epsilon Healthcare
USOTC
WEJOF
Wejo (CE)
BOV
ITUBL310
ITUBL310 Ex:28,45
BIT
AGL
Autogrill
BOV
CASN3
CASAN ON
BIT
I07883
Intesa Sanpaolo
BIT
1ADS
Adidas
BIT
F14316
Vontobel Financial Produ...
BIT
C00173
Commerzbank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유